Enterprise Bancorp (NASDAQ:EBTC) reported quarterly earnings of $1.01 per share. This is a 12.22 percent increase over earnings of $0.90 per share from the same period last year.
AbbVie’s Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability
Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the biosimilar market and prompting calls for regulatory reform to enhance patient access and incentivize development.
